Health Care & Life Sciences » Biotechnology | InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. | Ownership

Companies that own InVivo Therapeutics Holdings Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
169,661
2.19%
169,661
0.16%
06/30/2018
Heights Capital Management, Inc.
156,655
2.02%
156,655
0.01%
06/30/2018
Renaissance Technologies LLC
124,372
1.6%
117,976
0%
06/30/2018
Stonepine Capital Management LLC
77,900
1%
77,900
0.09%
06/30/2018
Anson Funds Management LP
54,450
0.7%
54,450
0.25%
06/30/2018
IMS Capital Management, Inc.
24,916
0.32%
-71
0.03%
06/30/2018
BlackRock Fund Advisors
19,953
0.26%
-2,754
0%
06/30/2018
The Vanguard Group, Inc.
18,373
0.24%
-15,867
0%
06/30/2018
Wedbush Securities, Inc. (Investment Management)
16,250
0.21%
12,488
0%
06/30/2018
Paulson Wealth Management Inc.
11,250
0.14%
11,250
0.02%
06/30/2018

About InVivo Therapeutics Holdings

View Profile
Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.invivotherapeutics.com
Updated 07/08/2019
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.